Am. Payne et al., Genetic analysis of the guanylate cyclase activator 1B (GUCA1B) gene in patients with autosomal dominant retinal dystrophies, J MED GENET, 36(9), 1999, pp. 691-693
Citations number
15
Categorie Soggetti
Research/Laboratory Medicine & Medical Tecnology","Molecular Biology & Genetics
The guanylate cyclase activator proteins (GCAP1 and GCAP2) are calcium bind
ing proteins which by activating Ret-GC1 play a key role in the recovery ph
ase of phototransduction. Recently a mutation in the GUCA1A gene (coding fo
r GCAP1) mapping to the 6p21.1 region was described as causing cone dystrop
hy in a British family. In addition mutations in Ret-GC1 have been shown to
cause Leber congenital amaurosis and cone-rod dystrophy. To determine whet
her GCAP2 is involved in dominant retinal degenerative diseases, the GCAP2
gene was screened in 400 unrelated subjects with autosomal dominant central
and peripheral retinal dystrophies.
A number of changes involving the intronic as well as the coding sequence w
ere observed. In exon 1 a T to C nucleotide change was observed leaving the
tyrosine residue 57 unchanged. In exon 3 a 1 bp intronic insertion, a sing
le nucleotide substitution G to A in the intron 3' of this exon, and a GAG
to GAT change at codon 155 were observed. This latter change results in a c
onservative change of glutamic acid to aspartic acid. In exon 4 a 7 bp intr
onic insertion, a single nucleotide A to G substitution in the intron 5' of
this exon, and a single base pair change C to G in the intron 3' of exon 4
were seen. None of these changes would be expected to affect correct splic
ing of this gene. All these changes were observed in controls. The results
of this study do not show any evidence so far that GCAP2 is involved in the
pathogenesis of autosomal dominant retinal degeneration in this group of p
atients. All the changes detected were found to be sequence variations or p
olymorphisms and not disease causing.